Trivascular Technologies, Revenue Growth Rates (TRIV), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Trivascular Technologies, Inc.  (TRIV)
 

TRIV's Revenue Growth by Quarter and Year

Trivascular Technologies,'s Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TRIV Revenue (in millions $) FY 2015 FY 2014 FY 2013 FY 2012
4th Quarter December -
3rd Quarter September 9.46
2nd Quarter June 9.73
1st Quarter March 8.03
FY 27.22





TRIV Revenue third quarter 2015 Y/Y Growth Comment
Trivascular Technologies, Inc. reported Revenue increase of 19.99% year on year in the third quarter 2015, to $ 9.46 millions, this is lower than Trivascular Technologies, Inc.'s recent average Revenue rise of 49.78%.

Looking into third quarter 2015 results within Medical Equipment & Supplies industry 40 other companies have achieved higher Revenue growth. While Trivascular Technologies, Inc.' s Revenue growth of 19.99% ranks overall at the positon no. 966 in the third quarter 2015.


TRIV Revenue ( Y/Y Growth %) 2015
 2014 2013 2012
4th Quarter December - 45.67 % - -
3rd Quarter September 19.99 % 43.01 % - -
2nd Quarter June 24.74 % 61.49 % - -
1st Quarter March 14.22 % 139.12 % - -
FY   - 62.91 % - -

Financial Statements
Trivascular Technologies,'s third quarter 2015 Revenue $ 9.46 millions TRIV's Income Statement
Trivascular Technologies,'s third quarter 2014 Revenue $ 7.88 millions Quarterly TRIV's Income Statement


TRIV Revenue (Quarter on Quarter Growth %)

 2015
 2014 2013 2012
4th Quarter December - 15.36 % 13.25 % -
3rd Quarter September -2.83 % 1.03 % 14.08 % -
2nd Quarter June 21.17 % 10.95 % 64.29 % -
1st Quarter March -11.66 % 12.66 % - -
FY (Year on Year)   - 62.91 % - -


Back to TRIV Growth rate Comparisons >> Back to TRIV Growth rate Comparisons >>


Revenue third quarter 2015 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #41
Healthcare Sector #178
Overall #966

Revenue Y/Y Growth Statistics
High Average Low
139.09 % 49.78 % 14.09 %
(Jun 30 2015)   (Mar 31 2015)
Revenue third quarter 2015 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #41
Healthcare Sector #178
Overall #966
Revenue Y/Y Growth Statistics
High Average Low
139.09 % 49.78 % 14.09 %
(Jun 30 2015)   (Mar 31 2015)

Revenue by Quarter for the Fiscal Years 2012, 2013, 2014, 2015

Trivascular Technologies,'s Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
21.28 % 5.66 % -11.7 %
(Jun 30 2015)  


TRIV's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2015 Trivascular Technologies, Inc. disclosed fall in Revenue from the second quarter by -2.83% to $ 9.46 millions, from $ 9.73 millions achived in the previous reporting period.

Although periodic circumstance commonly energize III. Quarter 2015 Revenue, this plainly could not be substantial to rescue Medical Equipment & Supplies's company achievement, Most analysts pointed out.

Within Medical Equipment & Supplies industry 102 other companies have achieved higher Revenue quarter on quarter growth. While Trivascular Technologies,'s Revenue growth quarter on quarter, overall rank is 3113.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #103
Healthcare Sector #412
Overall #3113
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #103
Healthcare Sector #412
Overall #3113
Revenue Q/Q Growth Statistics
High Average Low
21.28 % 5.66 % -11.7 %
(Jun 30 2015)  


TRIV's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2015 Trivascular Technologies, Inc. disclosed fall in Revenue from the second quarter by -2.83% to $ 9.46 millions, from $ 9.73 millions achived in the previous reporting period.

Although periodic circumstance commonly energize III. Quarter 2015 Revenue, this plainly could not be substantial to rescue Medical Equipment & Supplies's company achievement, Most analysts pointed out.

Within Medical Equipment & Supplies industry 102 other companies have achieved higher Revenue quarter on quarter growth. While Trivascular Technologies,'s Revenue growth quarter on quarter, overall rank is 3113.


Trivascular Technologies,'s 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2015)		 12 Months Ending
(Jun 30 2015)		 12 Months Ending
(Mar 31 2015)		 12 Months Ending
(Dec 31 2014)		 12 Months Ending
(Sep 30 2014)
Cumulative Revenue 12 Months Ending $ 36.30 $ 34.72 $ 32.79 $ 31.80 $ 0.00
Y / Y Revenue Growth (TTM) 25.41 % 30.68 % 38.94 % 63 % -
Year on Year Revenue Growth Overall Ranking # 2972 # 0 # 0 # 0 # 0
Seqeuential Revenue Change (TTM) 4.54 % 5.9 % 3.12 % 9.86 % -
Seq. Revenue Growth (TTM) Overall Ranking # 1733 # 0 # 0 # 0 # 0


Cumulative Revenue growth Comment
Assuming the Trivascular Technologies,'s fiscal year would have ended in Sep 30 2015, Trivascular Technologies, would have reprted above average annual Revenue rise of 25.41% year on year, of $ 36 millions.
This marks a slow-down of the companys growth trends and from the 30.68% improvement in Jun 30 2015.

In the Healthcare sector 349 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 2972.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 68
Healthcare Sector # 350
Overall # 2972

Revenue TTM Y/Y Growth Statistics
High Average Low
-33.4 %
 -33.4 %
-33.4 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 68
Sector # 244
S&P 500 # 1733
Cumulative Revenue growth Comment
Assuming the Trivascular Technologies,'s fiscal year would have ended in Sep 30 2015, Trivascular Technologies, would have reprted above average annual Revenue rise of 25.41% year on year, of $ 36 millions.
This marks a slow-down of the companys growth trends and from the 30.68% improvement in Jun 30 2015.

In the Healthcare sector 349 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 2972.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 68
Healthcare Sector # 350
Overall # 2972

Revenue TTM Y/Y Growth Statistics
High Average Low
-33.4 %
-33.4 %
-33.4 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 68
Sector # 244
S&P 500 # 1733




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
TRIV's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue improvement for the quarter ending Sep 30 2015 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2015
Oxford Immunotec Global Plc34.66%$ 34.664 millions
Ensign Group Inc34.60%$ 34.598 millions
Genmark Diagnostics Inc 34.48%$ 34.476 millions
Perrigo Company Plc33.80%$ 33.799 millions
Sanara Medtech Inc 33.35%$ 33.351 millions
Immune Design Corp.31.29%$ 31.292 millions
Biolife Solutions Inc 31.25%$ 31.250 millions
Encompass Health Corporation30.44%$ 30.441 millions
Repligen Corp29.69%$ 29.688 millions
Mylan N v 29.33%$ 29.328 millions
Magellan Health inc 28.91%$ 28.913 millions
Veru Inc 28.82%$ 28.823 millions
Heska Corporation28.57%$ 28.567 millions
Nanostring Technologies Inc 27.14%$ 27.141 millions
Tearlab Corp26.86%$ 26.861 millions
Biocardia Inc 26.04%$ 26.042 millions
Veracyte Inc 25.38%$ 25.381 millions
Tetraphase Pharmaceuticals Inc24.50%$ 24.499 millions
Sonoma Pharmaceuticals Inc 24.20%$ 24.203 millions
Vyant Bio Inc 24.16%$ 24.163 millions
Therapeuticsmd Inc 23.98%$ 23.981 millions
Cutera Inc 23.28%$ 23.278 millions
Wearable Health Solutions, Inc.21.38%$ 21.380 millions
Tenet Healthcare Corp21.15%$ 21.153 millions
Perspective Therapeutics Inc 21.04%$ 21.036 millions
Statera Biopharma Inc fka Cytocom Inc 20.82%$ 20.820 millions
Abeona Therapeutics Inc 20.76%$ 20.763 millions
Alexion Pharmaceuticals Inc 20.08%$ 20.083 millions
Trivascular Technologies, Inc.20.02%$ 20.018 millions
Portola Pharmaceuticals inc 19.98%$ 19.984 millions


About Trivascular Technologies, Revenue Growth Rates (TRIV), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.